
Advaccine
Founded Year
2009Stage
Series B - II | AliveTotal Raised
$99.74MLast Raised
$66M | 2 yrs agoAbout Advaccine
Advaccine is a biotech company focused on preventative and therapeutic vaccines. The company has a prophylactic and therapeutic vaccine pipeline driven by in-house developed technology platforms. It was founded in 2009 and is based in Beijing, China.
Advaccine Patents
Advaccine has filed 1 patent.
The 3 most popular patent topics include:
- Clusters of differentiation
- Immunology
- Molecular biology

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
8/5/2020 | 6/6/2023 | Olfactory receptors, Viral proteins, Immunology, Clusters of differentiation, Molecular biology | Grant |
Application Date | 8/5/2020 |
---|---|
Grant Date | 6/6/2023 |
Title | |
Related Topics | Olfactory receptors, Viral proteins, Immunology, Clusters of differentiation, Molecular biology |
Status | Grant |
Latest Advaccine News
Oct 14, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advaccine, Aerie, Agenus, Apeiron, Arcturus, Ascletis, Astellas, BMS, Inflarx, Inhibrx, Inovio, Istari, Otonomy, Vtv.
Advaccine Frequently Asked Questions (FAQ)
When was Advaccine founded?
Advaccine was founded in 2009.
Where is Advaccine's headquarters?
Advaccine's headquarters is located at Room B210, Level 2, Zone B 5 Kaituo Road, Haidian District, Beijing.
What is Advaccine's latest funding round?
Advaccine's latest funding round is Series B - II.
How much did Advaccine raise?
Advaccine raised a total of $99.74M.
Who are the investors of Advaccine?
Investors of Advaccine include Wosheng Investment, Matrix Partners China, StarCapital, Hony Capital, Star Sky Investment and 11 more.